Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Irhythm Technologies ( (IRTC) ).
iRhythm Holdings, Inc., a digital health specialist listed on Nasdaq under the ticker IRTC, appointed Jason Patten to its Board of Directors effective March 12, 2026. The company leverages wearable biosensors, cloud analytics, and proprietary algorithms to convert heart rhythm data into actionable clinical information, with a focus on improving outcomes through advanced cardiac monitoring.
iRhythm’s board move brings in Patten’s decades of strategic leadership in healthcare, including his current role as Executive Vice President and Head of Enterprise Strategy at UnitedHealth Group. The appointment underscores iRhythm’s push to scale profitably, expand access through primary care, and advance AI-driven, predictive care capabilities as it works toward building a billion-dollar platform grounded in clinical excellence and long-term value creation.
The most recent analyst rating on (IRTC) stock is a Buy with a $214.00 price target. To see the full list of analyst forecasts on Irhythm Technologies stock, see the IRTC Stock Forecast page.
Spark’s Take on IRTC Stock
According to Spark, TipRanks’ AI Analyst, IRTC is a Neutral.
The score is driven primarily by improving fundamentals and a positive outlook from the latest earnings call (growth, margin expansion, and rising free cash flow). Offsetting this are elevated balance-sheet leverage, still-negative profitability/negative P/E, and weak technicals with the stock trading below key moving averages.
To see Spark’s full report on IRTC stock, click here.
More about Irhythm Technologies
iRhythm Holdings, Inc. is a digital health care company that develops solutions to detect, predict, and prevent disease, primarily through wearable biosensors combined with cloud-based data analytics and proprietary algorithms. The company focuses on turning large volumes of cardiac data into clinically actionable insights, aiming to improve patient care by delivering better data, better insights, and better health outcomes.
Average Trading Volume: 662,889
Technical Sentiment Signal: Hold
Current Market Cap: $3.87B
See more insights into IRTC stock on TipRanks’ Stock Analysis page.